| Christopher James Sahlstrom, MD | |
|
4961 E Mayflower Ln, Wasilla, AK 99654-7708 | |
| (907) 357-3496 | |
| Not Available |
| Full Name | Christopher James Sahlstrom |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 19 Years |
| Location | 4961 E Mayflower Ln, Wasilla, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104858604 | NPI | - | NPPES |
| MD0506 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 6506 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heritage Family Medicine Llc | 5193869808 | 2 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the second quarter ended June 30, 2010.
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
Gilead Sciences, Inc. today announced the successful completion of the tender offer by its wholly-owned subsidiary, Royal Merger Sub II Inc., for all of the outstanding shares of common stock of Pharmasset, Inc. a price of $137 per share, net to the seller in cash.
The Global Fund to Fight AIDS, Tuberculosis and Malaria, "[a]long with our partners, both donors and implementers, is changing the story of scores of nations that were once devastated by three killer diseases - diseases which seemed invincible," Global Fund Executive Director Michel Kazatchkine writes in a Huffington Post opinion piece, adding "we are now saving more than one million lives every year."
› Verified 4 days ago
| Entity Name | Heritage Family Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699004853 PECOS PAC ID: 5193869808 Enrollment ID: O20100218000733 |
News Archive
Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the second quarter ended June 30, 2010.
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
Gilead Sciences, Inc. today announced the successful completion of the tender offer by its wholly-owned subsidiary, Royal Merger Sub II Inc., for all of the outstanding shares of common stock of Pharmasset, Inc. a price of $137 per share, net to the seller in cash.
The Global Fund to Fight AIDS, Tuberculosis and Malaria, "[a]long with our partners, both donors and implementers, is changing the story of scores of nations that were once devastated by three killer diseases - diseases which seemed invincible," Global Fund Executive Director Michel Kazatchkine writes in a Huffington Post opinion piece, adding "we are now saving more than one million lives every year."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher James Sahlstrom, MD 4961 E Mayflower Ln, Wasilla, AK 99654-7708 Ph: (907) 357-3496 | Christopher James Sahlstrom, MD 4961 E Mayflower Ln, Wasilla, AK 99654-7708 Ph: (907) 357-3496 |
News Archive
Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced financial results for the second quarter ended June 30, 2010.
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
Gilead Sciences, Inc. today announced the successful completion of the tender offer by its wholly-owned subsidiary, Royal Merger Sub II Inc., for all of the outstanding shares of common stock of Pharmasset, Inc. a price of $137 per share, net to the seller in cash.
The Global Fund to Fight AIDS, Tuberculosis and Malaria, "[a]long with our partners, both donors and implementers, is changing the story of scores of nations that were once devastated by three killer diseases - diseases which seemed invincible," Global Fund Executive Director Michel Kazatchkine writes in a Huffington Post opinion piece, adding "we are now saving more than one million lives every year."
› Verified 4 days ago
Dr. Robert Neubauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 Bogard Rd Ste 233, Wasilla, AK 99654 Phone: 907-352-2880 Fax: 907-352-2999 | |
Nathan Neves George, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 E Bogard Rd Ste 228, Wasilla, AK 99654 Phone: 907-376-8938 | |
Dr. Kristel Wyn Rush, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1363 W Spruce Ave, Wasilla, AK 99654 Phone: 907-376-2411 Fax: 907-352-3301 | |
Wade Erickson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3066 E Meridian Park Loop, Wasilla, AK 99654 Phone: 907-357-9593 | |
Laurie Elizabeth Dahms, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 S Knik Goose Bay Rd, Wasilla, AK 99654 Phone: 907-631-7800 Fax: 907-631-7612 | |
Dr. Duane I Odland, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 East Bogard, Suite 234, Wasilla, AK 99654 Phone: 907-373-0850 Fax: 907-373-0117 |